Dr. Bivas Biswas

Senior Consultant

18 Years of Experience

Medical Oncologist

MBBS, MD, DM

Reg. No.:60908, West Bengal Medical Council

English

Consultation Fee ₹ 1500

Book Appointment

Dr. Bivas Biswas is a highly accomplished Medical Oncologist with over 18 years of extensive experience.
He completed his MBBS from Medical College, Kolkata, followed by an MD in Paediatrics and DM in Medical Oncology from the All India Institute of Medical Science (AIIMS), New Delhi.
His areas of expertise include treating all types of solid tumors, lung cancer, sarcoma, melanoma, and genitourinary cancer.
He specializes in providing cytotoxic chemotherapy, targeted therapy, and immunotherapy for various cancers in their early to advanced stages.
During his tenure at AIIMS, Dr. Biswas earned a Gold Medal in Medical Oncology, showcasing his exceptional academic prowess.
He served as an Associate Professor at AIIMS, New Delhi, contributing significantly to medical education and research.
Dr. Biswas actively engages in clinical research, particularly focusing on lung cancer and urinary bladder cancer.
He is also involved in mentoring aspiring medical professionals pursuing the DNB super speciality course, which is accredited by the National Board of Education.
Dr. Biswas offers a comprehensive range of services catering to various oncology conditions, including gastrointestinal cancer and lung cancer.

Get a Treatment Plan Within 1 Hour

Name*

Mobile Number*

Query

MBBS
MD (Paediatrics) - All India Institute Of Medical Sciences (AIIMS), New Delhi
DM (Medical Oncology), All India Institute Of Medical Sciences (AIIMS), New Delhi

Clinical Predictors and Prognostic Model for Pediatric Lymphoblastic Lymphoma Treated With Uniform BFM90 Protocol: A Single-Center Experience of 65 Patients From Asia
Metronomic therapy in metastatic castrate-resistant prostate cancer: Experience from a tertiary cancer care center
A review on adverse event profiles of epidermal growth factor receptor-tyrosine kinase inhibitors in nonsmall cell lung cancer patients
Pretreatment neutrophilto lynphocyte ratio in ewing sarcoma family of tumors: An analysis of 570 patients.
Role of High Dose Radiotherapy for Locally Advanced Pancreatic Cancer – a Single Centre Experience from Eastern India
Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma in the Era of Targeted Therapy: Scientifically Relevant or Natural Selection?
287P Metronomic cyclophosphamide in metastatic castrate resistant prostate cancer: Experience from a tertiary cancer care center
506PD Ewing Sarcoma family tumors of vertebral column treated with uniform chemotherapy protocols: Experience from a tertiary cancer care center
506PD Ewing Sarcoma family tumors of vertebral column treated with uniform chemotherapy protocols: Experience from a tertiary cancer care center
Hypoalbuminemia and High WBC are Poor Predictors of Survival in Head and Neck Ewing Sarcoma Family of Tumors: An Updated Analysis of 59 Patients
Pretreatment Neutrophil to Lymphocyte Ratio Predicts Event Free and Overall Survival in Patients of Childhood T Cell Non-Hodgkin Lymphoma